Evidence map›Paper›PMID 40964093›Full record

ReviewFrontiers in cellular neuroscience2025

Research progress of kinesin family in neurological diseases.

Shuyi Liu, Jialing Chen, Liping Shi, Yuan Deng, Zhengbo Wang

Abstract readReview
In one paragraph

Review in Frontiers in cellular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuyi Liu *State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China.
Jialing Chen *State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China.
Liping ShiState Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China.
Yuan DengState Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China.
Zhengbo WangState Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kinesin superfamily proteins (KIFs) constitute a pivotal class of molecular motors that facilitate the intracellular transport of cellular "cargo." Their principal functions encompass the participation of the transport of cellular substances along microtubules, as well as the engagement in the formation of the mitotic spindle and the segregation of chromosomes during cellular mitosis. Dysregulation of KIFs expression can precipitate anomalies in intracellular material transport, mitotic abnormalities, aberrant cell proliferation and migration, and genomic instability within cells. Moreover, members of the KIFs are implicated in the proliferation of neural progenitor cells and the migration of neurons, which are critical processes in the development of the central nervous system. To date, an extensive body of research has substantiated the close correlation between mutations or aberrant expression of KIFs and the onset of neurological disorders, including neurotumors, neurodegenerative disease, and psychiatric illnesses. This review will synthesize recent research elucidating the nexus between KIFs and neurodevelopment, as well as their association with neurological diseases.

Indexed as

cancerkinesin superfamily proteinsnervous system diseaseneurodegenerative diseaseneurodevelopmentneurotumors

Identifiers

PMID40964093
PMCPMC12439720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.